KHB Shanghai Kehua Bio-Engineering Acquires the Italian Technogenetics PR Newswire (press release) KHB Shanghai Kehua Bio-Engineering Co., Ltd listed on the Shenzhen Stock Exchange (Stock Code 002022), one of the leading in vitro diagnostic (IVD) products developers in China, announced today the closure of the deal with Technogenetics, innovative ... |